abstract |
Provided herein is a deuterated compound of Formula (I) Formula (I) or a pharmaceutically acceptable salt thereof, wherein R 3a ,R 5 , R 6a , R 6b , R 17 , R 21a , R 21 b, R m , R n , R 16a , R 16 n b , R 7a , R 7b , R 12a , R 12b , R 11a R 11b , R 2a , R2 b , R 19 , R 4a , and R 4b are defined herein. Also provided herein are pharmaceutical compositions comprising a compound of Formula (I) and methods of using the compounds, e.g., in the treatment of CNS-related disorders. |